Anbex Awarded Bid from Hong Kong’s Department of Health
April 4, 2024
St. George-based Anbex has been awarded a bid from Hong Kong’s Department of Health for the supply of 187,040, 130mg IOSAT tablets. Anbex had previously won a similar-sized award from Hong Kong in 2021 on the supply of their potassium iodide tablets. Anbex is currently bidding on the supply of IOSAT tablets to Mexico, Argentina, Brazil, and Saudi Arabia. Anbex contracts with St. George-based Deseret Labs to manufacture the tablets.
For more information, visit anbex.com.
Recent News
- CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis
- HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM
- SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition
- First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
- Shedding Light On Cardiac Repair: How Red-Light Preconditioning Improves Cell Therapy
- Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand
